Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PHAR 359 > Endometriosis > Flashcards

Endometriosis Flashcards

(99 cards)

Start Studying
1
Q

What is endometriosis? Where can it present? What can it result in?

A

The presence of endometrial tissue outside of the uterus

It can present anywhere, but is commonly limited to the pelvic area

This can result in pain, and/or infertility (e.g. Endometrial tissue in fallopian tubes leading to blockage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the prevalence of endometriosis?

A

Affects ~10% of females of reproductive age

Affects up to 50% of women experiencing infertility

Affects ~70-80% of women experiencing chronic pelvic pain

Peak prevalence in those 25-35yo (Avg age at diagnosis is 27.9)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the cause of endometriosis?

A

The exact cause remains unknown

There are a few theories, however it is most likely multi-factorial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the theories for the cause of endometriosis

A
  1. Retrograde Menstruation Theory
  2. Immunologic Theory
  3. Coelomic Metaplasia Theory (Induction Theory)
  4. Vascular / Lymphatic Theory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe retrograde menstruation therapy

A

Endometrium shed during menstruation flows back through the fallopian tubes and becomes implanted on organs / tissues in the pelvic area

Rather than flowing out through the vagina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the immunologic theory for endometriosis

A

An underlying, immunologic disorder is responsible

Endometrial tissue is able to evade the immune system (deficient cell-mediated immunity)

This theory is supported by the presence of abnormal B & T cell function, and altered levels of cytokines & IL’s in endometrial lesions

Some of these changes may create an environment which is toxic to sperm (contributing to infertility)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the coelomic metaplasia theory for endometriosis

A

Coelomic Metaplasia Theory (Induction Theory)

The coelomic epithelium is epithelial tissue that lines the surface of the abdominal organs

Lesions develop when cells covering the peritoneum undergo metaplasia. I.e. normal peritoneal tissue transforms via metaplastic transition to ectopic endometrial-like tissue

Metaplasia – Once cell type to another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the vascular/lymphatic theory for endometriosis

A

Endometrial cells are spread to distant locations via the lymphatic system or vascular pathways (i.e. to the lung, brain, eyes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the pathophysiology of endometriosis?

A

Endometrial tissue deposits outside the uterus (likely via retrograde menstruation)

These implants are dependent on estrogen (E) - they can grow & bleed similar to the uterine lining during a menstruation cycle

Aromatase is present in lesions, leading to ↑ E
Decreased progesterone (P) receptors, hence P can’t antagonize the effects of E: “progesterone-resistance”

Overall, there is ↑ E stimulation of the endometriosis

Stimulation by E can stimulate PGE2, COX2 – i.e. can have pro-inflammatory effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the relationship between estrogen and pain in endometriosis

A

Repetitive cycles of bleeding and inflammation may lead to adhesions and scarring on adjacent tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some of the reasons for pain in endometriosis?

A

Inflammation
Immune responses to the endometrial lesions may lead to ↑ levels of pro-inflammatory cytokines

Neuropathic Pain
Endometrial lesions may compress on nerve fibres or adjacent structures

Central sensitization
Persistent pain can alter response to stimuli, leading to central sensitization (i.e. ↑ pain perception)

Bleeding from endometrial tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the relationship between pain and severity of endometriosis

A

Pain is not indicative of severity

e.g. a large amount of pain is not indicative of a severe pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Is endometriosis in regards to the experience of pain often diagnosed as endometriosis?

A

Endometriosis may not be discovered until one is investigated for infertiity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the hallmarks of the pathophysiology of endometriosis? What is the course of endometriosis?

A

Genetic predisposition
Estrogen dependence
Progesterone resistance
Inflammation

Endometriosis may remain stable, regress, or progress (approximately 1/3 each)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some risk factors for endometriosis?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the major symptoms of endometriosis? Are the sx the same for everyone? Are sx indicative of the severity of the condition?

A

Pain

Sub/Infertility (reason why most seek MD)

Note: Sx’s vary from person to person, are unpredictable, and up to 1/3 may be asymptomatic

Sx’s also do not always correlate with extent of the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the clinical presentation of endometriosis

A

Major symptom: pain
dysmenorrhea (80-90%)
chronic pelvic pain
–> Non-cyclical abdominal and pelvic pain ≥6 months
dyspareunia (30%)
painful defecation / urination
lower back pain

*** Can still worsen at times in the cycle – Can occur at any time in the cycle **

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the timeline of pain in endometriosis

A

Pain can be intermittent or constant; often occurs with menstrual cycle, but can occur anytime in cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are some other signs and symptoms of endometriosis that an individual may experience?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

In what other conditions should endometriosis be suspected?

A

Endometriosis should be suspected in women complaining of subfertilty, dysmenorrhea, dyspareunia, or chronic pelvic pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the impact of endometriosis

A

Functional impairments across domains: Psychological, Social, Occupational, and Academic

Persistent pain and decreased QOL

Disruption in work and studies

Physical and mental toll

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the diagnosis of endometriosis

A

Average 6-12yrs between initial sx’s and diagnosis
–> Pain is shared with many diseases, leading to a delay

The diagnosis is based on a thorough history, physical exam, and imaging assessments

The gold standard is visualization at laparoscopy and histological study**
–> Can determine extent of dx, but is not required before treatment can be started

** Histological examination of endometrial lesions**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe the staging of endometriosis. Issue with staging?

A

Limited clinical usefulness - Does not correlate with sx severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Is there a cure for endometriosis?

A

There is no cure, so treatment is aimed at management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Describe the goals of therapy for endometriosis
The goals of treatment will vary depending on the person’s desired outcomes: Relieve symptoms Improve fertility
26
What are the tx options for endometriosis? What is treatment based on?
Tx options: surgery, pharmacotherapy, or both Treat based on symptoms, preference, and priorities
27
Describe the management of sx associated with suspected or confirmed endometriosis?
Diagnosis made and then patient decides if sx control or fertility
28
Describe the first line pharamcotherapy options for endometriosis. Benefit?
1st line: Hormonal therapies Combined hormonal contraceptives (CHC) Progestins Oral, IM, SC implants, IUD Similarly effective to later treatment options but with fewer AEs and less $ NSAIDs: can help for dysmenorrhea
29
Describe the goals of hormonal therapy
1) Supress the menstrual cycle 2) Create amenorhhea 3) Stop ovulation if that process is painful
30
Describe the role of combined hormonal contraceptives?
Suppress ovulation and the growth of implants They decrease hormone levels, & they keep the menstrual cycle regular, shorter, and lighter
31
With oral combined hormonal contraceptives, does the estrogen component stimulate endometrial tissue growth?
The estrogen used (ethinyl estradiol) has less estrogenic activity than endogenous estradiol, and the progestin helps prevent a rise in estradiol Does not cause endometrial lesions to grow
32
Describe who oral combined hormonal contraceptive is useful for
Ideal for people with no current desire to get pregnant
33
Describe the dosing of CHC's in endometriosis
They can be used cyclically or continuously Some evidence favours continuous use
34
Describe the evidence for the use of CHC's in endometriosis? Safety?
Trials show clinically significant ↓ in endo-related pain Evidence primarily with OCPs (but patch or vaginal ring are options as well) They are safe and can be used long-term
35
What are some of the side effects of CHC?
SE’s (i.e. breast tenderness, h/a, nausea, weight gain, mood changes), precautions (i.e DVT risk), and contraindications
36
Describe the tolerability of CHC compared to other hormonal therapies in endometriosis
CHCs are considerably better tolerated than alternative hormonal options (and less $)
37
What are some of the initial potential adverse effects of COC? Management of the side effects?
Common in first 3 months of starting pill: Breakthrough bleeding (BTB) (Spotting – Not a full on period) –> Check adherence –> If lasts >6 months look for other causes (STIs) – check at how they are taking the pill, if forgetting, different times –> Change to pill with ↑ estrogen/progestin (depending when BTB occurs in cycle) Breast tenderness –> If lasts longer than first 3 months, look for other causes Change to pill with ↓ estrogen Nausea Take at HS or with food Change to pill with ↓ estrogen Weight gain (controversial) Some notice ↑ appetite in first month, but overall little or minimal weight gain Remember weight fluctuates with age and water retention Headache or migraine Can be hormone-related Can either ↓ or ↑ with use Mood changes – Depression –> Observational study Acne Can worsen initially…but… Usually improves with long-term use Several OC have official indications for acne…but all combined OC can be beneficial –> Lowers amount of endogenous androgens produced or (bio)available (androgens stimulate sebum production → acne) If a continued problem, change to pill with ↓ androgenic activity Or use topical therapy
38
What are some of the potential risks of COC?
Contraceptive failure Especially if missed pills with <20mcg estrogen (less s/e; however, need good adherence) Venous thromboembolism (VTE) Risk is 2-3x higher than in non-users Risk ↑ with age, smoking, ↑ estrogen dose Controversy whether drospirenone increases risk MI and stroke (arterial thrombosis) ↑ risk associated with estrogen >50mcg day, age >35 years, smoking, HTN and other CVD risks
39
What are some of the early signs of the risks associated with COC?
A – Abdominal pain (severe) Gallbladder, pancreatitis, thrombosis C – Chest pain (severe) or shortness of breath Pulmonary embolus or myocardial infarction H – Headaches (severe) Stroke, hypertension, migraine E – Eye problems (blurring, flashing, vision loss) Stroke, hypertension, vascular insufficiency S – Severe leg pain (calf or thigh) DVT
40
What are some drug interactions that alter the levels of COC? How can they be managed?
CPY450 3A4 inducers Anticonvulsants (carbamezapine, phenytoin) Anti-infectives (rifampin) Herbals (St John’s wort) Management: Use product with higher estrogen levels (>30ug EE) Use extended dosing (skip HFIs) Use alternative to interacting drug or other method of birth control
41
What drugs metabolism is altered by combined OC? Management?
Metabolism altered by oral contraceptives Lamotrigine (significantly ↓ levels – induction of lamotrigine glucuronidation) Management Use alternative to interacting drug or other method of birth control
42
What are some of the contraindications of COC?
Thromboembolic disease Current or past VTE Hypertension (>160/100mmHg) Ischemic heart disease / Stroke Known or suspected breast cancer Migraine with aura Severe / active liver disease Post-partum –> Wait least 3-6 weeks post-partum b/c increased risk of VTE Smokers (>15 cigs/day) Over 35 years old
43
What are the two types of the progestin-only pills?
Norethindrone 35mcg daily (no HFI) Drospirenone 4mg OD x 24 days then 4 placebo pills
44
Describe the MOA of norethindrine?
Alters cervical mucus and endometrium (main moa)
45
Describe the MOA of drosperinone?
Primarily suppresses ovulation
46
Describe the indication of progestin-only contraceptives?
Estrogen contraindicated History/risk of blood clots (VTE) Smoker >35 years old Obese Migraine Breastfeeding – won’t decrease milk supply
47
What are the adverse effects of progestin only pills?
Irregular bleeding (more so in first months) Headache Bloating, wgt gain (water) Acne Breast tenderness Potential to ↑ K+ (monitor if risk for hyperkalemia) --> Drosperinone, monitor it
48
What are some contraindications of the progestin only pills?
Liver disease Breast cancer Drug interactions similar to combined OC
49
What are some of the progestins hormonal therapy? How do they work?
They help prevent the rise in estradiol, without estrogen related stimulation of endometriotic growth, & induce a hypoestrogenic environment Can help with dysmenorrhea symptoms
50
Describe the efficacy of progestins compared to other contraceptives in endometriosis?
Similar efficacy to other hormonal therapies
51
What are some adverse effects of progestin contraceptives in endometriosis?
AE’s - breakthrough bleeding, weight gain/fluid retention, mood changes, h/a Depot: may delay the return in ovulation, and decraesed BMD with prolonged use Dienogest: may be detrimental to BMD (especially adolescants, adults can be reversed), associated with less anti-androgenic effects, requires non-hormonal contraception IUS: risk of expulsion; long-term effect on BMD unknown
52
Counselling point regarding contraception in endometriosis
A minimum of a 3 month trial should be tried prior to moving on to subsequent treatment options for pain control
53
Describe the MOA of NSAID's in endometriosis
MOA: interfere with PG synthesis (which is overexpressed in endometrial lesions)
54
Describe the evidence for NSAIDs in endometriosis and there role in therapy for endometriosis
Is a lack of high-quality evidence assessing their efficacy, and no evidence favouring one over another1 Appropriate 1st choice if sx’s are mild & women do not want to take a hormonal treatment option Appropriate to use in conjunction with hormonal tx options
55
Describe the dosing of NSAIDs in endometriosis
Dosing: use on a scheduled basis --> can administer intermittently or continuously Counsel differently if continuous or intermittently
56
What are some precautions associated with NSAIDs?
Precautions: GI, renal, reactive airway disease
57
What are some other analgesics (besides NSAIDs) that can be used in endometriosis?
Acetaminophen: --> Perhaps for milder symptoms… Narcotic analgesics: --> Codeine, hydrocodone, others
58
What are GnRH agonists in endometriosis ?
Gonadotropin-Releasing Hormone (GnRH) Agonists Synthetic analogs of human GnRH
59
Describe the MOA of GnRH agonists in endometriosis?
Bind to GnRH receptors in the pituitary, and initially cause an ↑ release of LH/FSH Due to their long t½ , down-regulation of the hypothalamic-pituitary-ovarian axis occurs This prevents the release of endogenous GnRH from the hypothalamus, blocking the release of FSH/LH, and results in a hypoestrogenic state, endometrial atrophy, and amenorrhea
60
Describe the role of GnRH in the menstrual cycle
Feedback Loop GNRH initial increase sin LH and FSH - Increases estrogen and then progesterone
61
What is an example of a GnRH agonist?
Lupron Depot - Leuprolide acetate
62
Describe the duration of use of lupron depot for endometriosis? Why? Other counselling point/concern?
Sx may temporaily worsen after first dose and then improve in one month Limited to 6 months of use – Adverse effect profile Product monographs say treatment up to 6 months – treatment duration is determined by the prescriber
63
Describe lupron therapy in regards to endometriosis and the menstrual cycle
64
Describe the avilable GnRH agonits in Canada
65
Describe the overall side effects that may occur from GnRH agonist therapy
bone loss vasomotor symptoms (hot flashes, night sweats, vaginal dryness, insomnia, decreased libido) Other common side effects: Headache/migraine mood swings
66
What are the side effects of GnRH agonists analagous with?
Sx’s are analogous to menopause due to near-depletion of E. To combat, add-back therapy can be used
67
Prior to GnRH agonist therapy, what is required prior to administration?
Rule out pregnancy before use; use non-hormonal birth control while taking
68
What is add back treatment regarding GnRH agonist therapy in endometriosis?
To counter bone loss and vasomotor symptoms, a low dose estrogen +/or progestin should be added E.g. Estrace 1mg + MPA 2.5mg od E.g. CES 0.625mg + norethindrone acetate 5mg od E.g. Norethindrone acetate 5mg od Note: not combined oral contraceptives
69
Describe how add back therapy in GnRH agonist therapy maintains efficacy of the GnRH agonist?
E.g. Estrace 1mg + MPA 2.5mg od E.g. CES 0.625mg + norethindrone acetate 5mg od E.g. Norethindrone acetate 5mg od Add back estrogen with or without progestin These regimens decrease AE’s yet maintain efficacy HOW? Theory: there is an estrogen threshold effect
70
Why are COHC not used for GnRH therapy?
Combined oral contraceptives (COCs) are not the preferred add-back therapy because they have limited bone protection effects. Sex hormone-based add-back therapy is the preferred method for these treatments because it can effectively protect bone mass
71
When add back therapy is used with GnRH agonists, what is the duration of use?
When add back tx used – Can be used for up to 12 months
72
Describe the efficacy of leuprolide acetate
Norethindrorne is a progestin – Estrogenic and androgenic properties
73
Why is add back therapy used alongside GnRH agonists? Efficacy of add back tx?
Add back therapy prevents bone loss with GnRH agonists
74
Describe the female sex Hypothalmus-Pituatry-Gonad (ovarian) Axis
75
What is an example of a GnRH antagonist?
Elagolix (Orilissa) 2018: first FDA oral medication approved for moderate –severe endometrial pain in over a decade
76
Describe the MOA of GnRH antagonists and its role in endometriosis therapy
An oral GnRH receptor antagonist --> it competitively binds to GnRH in the pituitary and suppresses gonadotropins & causes rapid, reversible, dose-dependent hypoestrogenic state
77
Describe the dosing of elagolix
Partial estradiol suppression: 150mg daily Nearly full estradiol suppression: 200mg BID (reserved for severe refractory cases) Start at lower dose as there is a dose-dependent decrease in BMD; adjust based on symptoms
78
Is there a difference between GnRH antagonists and agonists in the treatment of endometriosis?
Similar efficacy as GNRH agonist
79
Describe the administration of Elagolix
Can be taken with or without food. Begin at time of menstruation; patients should use an effective method of contraception not containing estrogen
80
Describe the adverse effects of Elagolix
ADVERSE EFFECTS: hot flashes, headache, insomnia, nausea, amenorrhea, mood swings, night sweats Dose-dependent increases in TC, LDL, TG, and decrease in BMD Changes in cholesterol returned to baseline; BMD recovery started at 6 months
81
Describe the drug interactions of Elagolix
DRUG INTERACTIONS: CYP interactions
82
Describe the efficacy of Elagolix
Both reduce dysmenorhhea and non-menstrual pelvic pain – Higher dose does it more effectively
83
Describe the critical counselling points associated with GnRH antagonist therapy
Rule out pregnancy before beginning Use a non-estrogen contraceptive Estrogen will reduce efficacy – Can sue progestin only and non-hormonal 200mg BID x 6mos is max use due to BMD concerns / not studied beyond 1 year Ensure adequate calcium and Vitamin D intake Can cause alterations in bleeding patterns Common side effects – hot flashes, headache, nausea, insomnia, mood changes
84
What are some examples of aromatase inhibitors?
Anastrozole, letrozole, exemestane
85
Describe the MOA of aromatase inhibitors in endometriosis
Aromatase is a key enzyme in the conversion of adrenal androgens to estrogens By inhibiting aromatase, it will lower overall estrogen
86
Describe the efficacy of aromatase inhibitors in endometriosis
Efficacy: not a lot of evidence available, but some signals they decraese pain alone or in combo with CHCs, progestins, and GnRH agonists Not routinely recommended – Use if other options have not worked More used in breast cancer and post-menopausal women in studied
87
What are some side effects of aromatase inhibitors? Comparison to other therapies?
SE’s: h/a, nausea, diarrhea (mild), hot flash, vaginal dryness - Less than GnRH agonists - Long-term use may impact BMD – may consider add-back therapy with CHC or progestin
88
Describe the MOA and role of Danazol in endometriosis
A synthetic androgen derived from 17-ethinyl testosterone Induces a pseudomenopausal state by increased androgen levels & decreased estrogen levels (it suppresses the production of LH & FSH) Estradiol suppression will cause anovulation, amenorrhea, and atrophy of the endometrial tissue
89
Describe the efficacy of danazol in endometriosis
Efficacy: 80-90% achieve symptomatic improvement However, use is no longer supported due to androgenic AEs (voice changes, weight gain, hair growth, acne, negative impact on lipid profile) Rarely used due to side effects
90
Describe the dose of danazol in endometriosis
Dose: 600-800mg/d (divided BID) for ~6 months (po or vaginal)
91
When is surgical management of endometriosis considered?
For those: who are infertile and desire pregnancy not responding to pharmacologic therapies
92
What is the main surgical management method of endometriosis pain?
Conservational Treatment: Laparoscopy
93
Describe the expectations after laparoscopic surgery of endometriosis
94
What are some other surgical interventions that may be used for tx of endometriosis? Concern?
Hysterectomy with or without oophorectomy TAH-BSO (total abdominal hysterectomy - bilateral salpingo-oophorectomy) + removal of all visible endometriosis It does not guarantee resolution of sx’s – up to 10% may have pain recurrence at 1 year Ovaries removed – Menopause – Low dose hormones used
95
What is the Alliance for Endometriosis? Statistics?
Aim: to eliminate stigma and encourage conversations to speed up diagnosis and improve treatment options
96
Describe pregnancy and fertility concerns in endometriosis?
Generally recommend waiting 1 month after d/c medical therapy before trying to conceive If pregnancy occurs, endometriosis generally enters remission with pregnancy PLAN AHEAD HERE
97
Describe the proposed explanations for infertility associated endometriosis
Changes in characteristics of peritoneal fluid Extensive scarring from endometrial lesions distorts pelvic anatomy causing mechanical obstruction Autoimmune mechanisms Increased concentrations of inflammatory cells; hostile environment to sperm/embryo Increased uterine peristaltic activity, which may prevent embryo implantation Irregularities in menstrual cycle
98
What are some of the management options for infertility-associated endometriosis?
99
Describe the role of the pharmacist in the management of endometriosis

PHAR 359 (8 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions